Intravenous insulin-like growth factor-I receptor antisense treatment reduces angiotensin receptor expression and function in spontaneously hypertensive rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 3, 2006, Pages 1171-1177

  Tien, Thuy Nguyen ^a   Cao, Nga ^a   Short, Jennifer Lynn ^a   White, Paul James ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; NORADRENALIN; SOMATOMEDIN C RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA MEDIA; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CONDUCTANCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TAIL ARTERY; VASCULAR RESISTANCE;

ANGIOTENSIN II; ANIMALS; ANTISENSE ELEMENTS (GENETICS); BLOOD PRESSURE; FEMALE; HYPERTENSION; INJECTIONS, INTRAVENOUS; NOREPINEPHRINE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, IGF TYPE 1; VASOCONSTRICTION;

EID: 33747616658     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.103655     Document Type: Article

References (23)

1. Brink M, Chrast J, Price SR, Mitch WE, and Delafontaine P (1999) Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake. Hypertension 34:1053-1059.
2. Chen Y, Bornfeldt KE, Arner A, Jennische E, Malmqvist U, Uvelius B, and Arnqvist HJ (1994) Increase in insulin-like growth factor I in hypertrophying smooth muscle. Am J Physiol 266:E224-E229.
3. Delafontaine P and Lou H (1993) Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem 268:16866-16870.
4. Du J and Delafontaine P (1995) Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA. Circ Res 76:963-972.
5. G-Monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF-I: possible role of nitric oxide in muscle protein synthesis. J Clin Investig 97:1319-1328.
6. Grisk O (2005) Sympatho-renal interactions in the determination of arterial pressure: role in hypertension. Exp Physiol 90:183-187.
7. Hu ZW, Shi XY, and Hoffman BB (1996) Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells. J Clin Investig 98:1826-1834.
8. Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, and Anversa P (2001) IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50:1414-1424.
9. Kambayashi Y, Nagata K, Ichiki T, and Inagami T (1996) Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells. Eur J Biochem 239:558-565.
10. Kamide K, Hori MT, Zhu JH, Takagawa Y, Barrett JD, Eggena P, and Tuck ML (2000) Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells. J Hypertens 18:1051-1056.
11. Khorsandi MJ, Fagin JA, Giannella-Neto D, Forrester JS, and Cercek B (1992) Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J Clin Investig 90:1926-1931.
12. Leri A, Liu Y, Wang X, Kajstura J, Malhotra A, Meggs LG, and Anversa P (1999) Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res 84:752-762.
13. McCallum RW, Hamilton CA, Graham D, Jardine E, Connell JM, and Dominiczak AF (2005) Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats. J Hypertens 23:351-358.
14. McDougall SJ, Roulston CA, Widdop RE, and Lawrence AJ (2000) Characterisation of vasopressin V(1A), angiotensin AT(1) and AT(2) receptor distribution and density in normotensive and hypertensive rat brain stem and kidney: effects of restraint stress. Brain Res 883:148-156.
15. Muller C, Reddert A, Wassmann S, Strehlow K, Bohm M, and Nickenig G (2000) Insulin-like growth factor induces up-regulation of AT(1)-receptor gene expression in vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst 1:273-277.
16. Nguyen TT and White PJ (2005) Intravenous IGF-I receptor antisense reduces IGF-IR expression and diminishes pressor responses to angiotensin II in conscious normotensive rats. Br J Pharmacol 146:935-941.
17. Nolan BP, Senechal P, Waqar S, Myers J, Standley CA, and Standley PR (2003) Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia. Am J Hypertens 16:393-400.
18. Pete G, Hu Y, Walsh M, Sowers J, and Dunbar JC (1996) Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc Soc Exp Biol Med 213:187-192.
19. Sidawy AN, Termanini B, Nardi RV, Harmon JW, and Korman LY (1990) Insulin-like growth factor I receptors in the arteries of the rabbit: autoradiographic mapping and receptor characterization. Surgery 108:165-170; discussion 170-161.
20. Tivesten A, Bollano E, Andersson I, Fitzgerald S, Caidahl K, Sjogren K, Skott O, Liu JL, Mobini R, Isaksson OG, et al. (2002) Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143:4235-4242.
21. Vecchione C, Colella S, Fratta L, Gentile MT, Selvetella G, Frati G, Trimarco B, and Lembo G (2001) Impaired insulin-like growth factor I vasorelaxant effects in hypertension. Hypertension 37:1480-1485.
22. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, and Sowers JR (1996) Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 137:1798-1803.
23. Wraight CJ, White PJ, McKean SC, Fogarty RD, Venables DJ, Liepe IJ, Edmondson SR, and Werther GA (2000) Reversal of epidermal hyperproliferation in psoriasis by insulin-like growth factor I receptor antisense oligonucleotides. Nat Biotechnol 18:521-526.